A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration (original) (raw)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration

Claudia Jara

Frontiers in neuroscience, 2018

View PDFchevron_right

March separate, strike together — Role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease

Amandine Grimm

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014

View PDFchevron_right

Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice

Margrethe Olesen

Scientific Reports

View PDFchevron_right

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease

Mar Cuadrado-Tejedor

International Journal of Molecular Sciences, 2021

View PDFchevron_right

Insights into Disease-Associated Tau Impact on Mitochondria

Amandine Grimm

International Journal of Molecular Sciences, 2020

View PDFchevron_right

NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease

veronica corsetti

Human molecular genetics, 2015

View PDFchevron_right

Role of tau in Alzheimer’s dementia and other neurodegenerative diseases

Ghania Ait-Ghezala

View PDFchevron_right

Truncated tau and Aβ cooperatively impair mitochondria in primary neurons

Youngnam Jin

Neurobiology of Aging, 2012

View PDFchevron_right

NH 2 -truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's Disease Downloaded from

Fulvio Florenzano

View PDFchevron_right

Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease

Claudia Jara

Molecular Neurobiology, 2017

View PDFchevron_right

Brief update on different roles of tau in neurodegeneration

Janet Van Eersel, Arne Ittner

IUBMB Life, 2011

View PDFchevron_right

Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

George Perry

Neurochemistry International, 2002

View PDFchevron_right

Tau modifiers as therapeutic targets for Alzheimer's disease

Atsushi Takeda

… et Biophysica Acta (BBA …, 2005

View PDFchevron_right

Convergence of amyloid-β and tau pathologies on mitochondria

Laurence Ozmen

Alzheimers & Dementia - ALZHEIMERS DEMENT, 2010

View PDFchevron_right

A Novel Perspective on Tau in Alzheimers Disease

George Perry

Current Alzheimer Research, 2011

View PDFchevron_right

Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease

Ramesh Kandimalla

Human molecular genetics, 2018

View PDFchevron_right

Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice

rivka ravid

Journal of Biological Chemistry, 2005

View PDFchevron_right

Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria

4jk19cs006 Albin John

Ageing Research Reviews, 2021

View PDFchevron_right

Tau Abnormalities and the Potential Therapy in Alzheimer's Disease

Mahaman Yacoubou

View PDFchevron_right

Post-translational modifications of tau protein in Alzheimer’s disease

Khalid Iqbal

Journal of Neural Transmission, 2005

View PDFchevron_right

Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration

Luka Kulic

Neurobiology of Aging, 2011

View PDFchevron_right

Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

nadia soussi-yanicostas

Oxidative Medicine and Cellular Longevity, 2015

View PDFchevron_right

Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy

Marie-christine Galas

Acta Neuropathologica Communications

View PDFchevron_right

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Male and Female Mice

su youne Chang

2020

View PDFchevron_right

Specific post-translational modifications of soluble tau protein distinguishes Alzheimer’s disease and primary tauopathies

Pascal Kienlen-Campard

Nature Communications

View PDFchevron_right

The Role of Tau in Alzheimer's Disease and Related Disorders: Role of Tau in AD and Related Disorders

Frank LaFerla

Cns Neuroscience & Therapeutics - CNS NEUROSCI THER, 2010

View PDFchevron_right

Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio

Joanna B Strosznajder

Antioxidants & Redox Signaling, 2012

View PDFchevron_right

The Role of Tau in Alzheimer's Disease and Related Disorders

Rodrigo Medeiros

CNS Neuroscience & Therapeutics, 2010

View PDFchevron_right

Truncated tau from sporadic Alzheimer’s disease suffices to drive neurofibrillary degeneration in vivo

Michal Novak, Peter Filipcik

FEBS Letters, 2006

View PDFchevron_right

Tau pathology in Alzheimer disease and other tauopathies

Abdur Rahman

Biochimica Et Biophysica Acta-molecular Basis of Disease, 2005

View PDFchevron_right